The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Split Influenza Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2029
Synopsis
The global Split Influenza Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Influenza virus split vaccine is made by inoculating chicken embryos with influenza virus strains recommended by the World Health Organization (WHO) and approved by the national drug administration department, cultured, harvested virus liquid, virus inactivated, purified, and cracked. For the prevention of influenza caused by this type of virus.
This report is a detailed and comprehensive analysis for global Split Influenza Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Split Influenza Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Split Influenza Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Split Influenza Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Split Influenza Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Split Influenza Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Split Influenza Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi Pasteur, CSL Seqirus, GSK, Seqirus, Inc. and straZeneca and etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Split Influenza Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Aldult
Child
Market segment by Application
Hospital
Clinic
Major players covered
Sanofi Pasteur
CSL Seqirus
GSK
Seqirus, Inc.
straZeneca
Dalian Yali Peak
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Split Influenza Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Split Influenza Vaccine, with price, sales, revenue and global market share of Split Influenza Vaccine from 2018 to 2023.
Chapter 3, the Split Influenza Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Split Influenza Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Split Influenza Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Split Influenza Vaccine.
Chapter 14 and 15, to describe Split Influenza Vaccine sales channel, distributors, customers, research findings and conclusion.
The global Split Influenza Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Influenza virus split vaccine is made by inoculating chicken embryos with influenza virus strains recommended by the World Health Organization (WHO) and approved by the national drug administration department, cultured, harvested virus liquid, virus inactivated, purified, and cracked. For the prevention of influenza caused by this type of virus.
This report is a detailed and comprehensive analysis for global Split Influenza Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Split Influenza Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Split Influenza Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Split Influenza Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Split Influenza Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Split Influenza Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Split Influenza Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi Pasteur, CSL Seqirus, GSK, Seqirus, Inc. and straZeneca and etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Split Influenza Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Aldult
Child
Market segment by Application
Hospital
Clinic
Major players covered
Sanofi Pasteur
CSL Seqirus
GSK
Seqirus, Inc.
straZeneca
Dalian Yali Peak
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Split Influenza Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Split Influenza Vaccine, with price, sales, revenue and global market share of Split Influenza Vaccine from 2018 to 2023.
Chapter 3, the Split Influenza Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Split Influenza Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Split Influenza Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Split Influenza Vaccine.
Chapter 14 and 15, to describe Split Influenza Vaccine sales channel, distributors, customers, research findings and conclusion.
Index1 Market Overview
1.1 Product Overview and Scope of Split Influenza Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Split Influenza Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Aldult
1.3.3 Child
1.4 Market Analysis by Application
1.4.1 Overview: Global Split Influenza Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Split Influenza Vaccine Market Size & Forecast
1.5.1 Global Split Influenza Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Split Influenza Vaccine Sales Quantity (2018-2029)
1.5.3 Global Split Influenza Vaccine Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Sanofi Pasteur
2.1.1 Sanofi Pasteur Details
2.1.2 Sanofi Pasteur Major Business
2.1.3 Sanofi Pasteur Split Influenza Vaccine Product and Services
2.1.4 Sanofi Pasteur Split Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sanofi Pasteur Recent Developments/Updates
2.2 CSL Seqirus
2.2.1 CSL Seqirus Details
2.2.2 CSL Seqirus Major Business
2.2.3 CSL Seqirus Split Influenza Vaccine Product and Services
2.2.4 CSL Seqirus Split Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 CSL Seqirus Recent Developments/Updates
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK Split Influenza Vaccine Product and Services
2.3.4 GSK Split Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 GSK Recent Developments/Updates
2.4 Seqirus, Inc.
2.4.1 Seqirus, Inc. Details
2.4.2 Seqirus, Inc. Major Business
2.4.3 Seqirus, Inc. Split Influenza Vaccine Product and Services
2.4.4 Seqirus, Inc. Split Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Seqirus, Inc. Recent Developments/Updates
2.5 straZeneca
2.5.1 straZeneca Details
2.5.2 straZeneca Major Business
2.5.3 straZeneca Split Influenza Vaccine Product and Services
2.5.4 straZeneca Split Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 straZeneca Recent Developments/Updates
2.6 Dalian Yali Peak
2.6.1 Dalian Yali Peak Details
2.6.2 Dalian Yali Peak Major Business
2.6.3 Dalian Yali Peak Split Influenza Vaccine Product and Services
2.6.4 Dalian Yali Peak Split Influenza Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Dalian Yali Peak Recent Developments/Updates
3 Competitive Environment: Split Influenza Vaccine by Manufacturer
3.1 Global Split Influenza Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Split Influenza Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Split Influenza Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Split Influenza Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Split Influenza Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Split Influenza Vaccine Manufacturer Market Share in 2022
3.5 Split Influenza Vaccine Market: Overall Company Footprint Analysis
3.5.1 Split Influenza Vaccine Market: Region Footprint
3.5.2 Split Influenza Vaccine Market: Company Product Type Footprint
3.5.3 Split Influenza Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Split Influenza Vaccine Market Size by Region
4.1.1 Global Split Influenza Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Split Influenza Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Split Influenza Vaccine Average Price by Region (2018-2029)
4.2 North America Split Influenza Vaccine Consumption Value (2018-2029)
4.3 Europe Split Influenza Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Split Influenza Vaccine Consumption Value (2018-2029)
4.5 South America Split Influenza Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Split Influenza Vaccine Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Split Influenza Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Split Influenza Vaccine Consumption Value by Type (2018-2029)
5.3 Global Split Influenza Vaccine Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Split Influenza Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Split Influenza Vaccine Consumption Value by Application (2018-2029)
6.3 Global Split Influenza Vaccine Average Price by Application (2018-2029)
7 North America
7.1 North America Split Influenza Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Split Influenza Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Split Influenza Vaccine Market Size by Country
7.3.1 North America Split Influenza Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Split Influenza Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Split Influenza Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Split Influenza Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Split Influenza Vaccine Market Size by Country
8.3.1 Europe Split Influenza Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Split Influenza Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Split Influenza Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Split Influenza Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Split Influenza Vaccine Market Size by Region
9.3.1 Asia-Pacific Split Influenza Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Split Influenza Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Split Influenza Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Split Influenza Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Split Influenza Vaccine Market Size by Country
10.3.1 South America Split Influenza Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Split Influenza Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Split Influenza Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Split Influenza Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Split Influenza Vaccine Market Size by Country
11.3.1 Middle East & Africa Split Influenza Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Split Influenza Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Split Influenza Vaccine Market Drivers
12.2 Split Influenza Vaccine Market Restraints
12.3 Split Influenza Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Split Influenza Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Split Influenza Vaccine
13.3 Split Influenza Vaccine Production Process
13.4 Split Influenza Vaccine Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Split Influenza Vaccine Typical Distributors
14.3 Split Influenza Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
